Staidson (Beijing) BioPharmaceuticals Co., Ltd. (SHE:300204)
16.66
+1.88 (12.72%)
May 23, 2025, 2:45 PM CST
SHE:300204 Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
Cash & Equivalents | 89.44 | 53.91 | 85.18 | 264.99 | 85.01 | 140.57 | Upgrade
|
Short-Term Investments | - | - | - | - | - | 120.73 | Upgrade
|
Trading Asset Securities | - | - | - | - | 381.46 | 461.24 | Upgrade
|
Cash & Short-Term Investments | 89.44 | 53.91 | 85.18 | 264.99 | 466.47 | 722.54 | Upgrade
|
Cash Growth | 42.00% | -36.71% | -67.86% | -43.19% | -35.44% | -8.52% | Upgrade
|
Accounts Receivable | 45.97 | 39.07 | 61.22 | 188.18 | 157.9 | 128.22 | Upgrade
|
Other Receivables | 0.7 | 0.64 | 1.14 | 1.38 | 1.18 | 1.29 | Upgrade
|
Receivables | 46.67 | 39.72 | 62.35 | 189.56 | 159.07 | 129.51 | Upgrade
|
Inventory | 26.51 | 22.18 | 20.93 | 18.83 | 25.01 | 38.09 | Upgrade
|
Prepaid Expenses | - | - | 0.01 | - | - | - | Upgrade
|
Other Current Assets | 63.1 | 61.81 | 70.41 | 55.69 | 37.9 | 13.17 | Upgrade
|
Total Current Assets | 225.71 | 177.62 | 238.89 | 529.06 | 688.44 | 903.32 | Upgrade
|
Property, Plant & Equipment | 228.85 | 235 | 261.36 | 290.58 | 312.43 | 295.17 | Upgrade
|
Long-Term Investments | 481.19 | 514.07 | 549.54 | 522.25 | 545.43 | 444.03 | Upgrade
|
Goodwill | 19.75 | 19.75 | 19.75 | 19.75 | 22.17 | 22.17 | Upgrade
|
Other Intangible Assets | 34.48 | 34.67 | 35.13 | 80.48 | 82.22 | 82.97 | Upgrade
|
Long-Term Deferred Tax Assets | 50.08 | 50.08 | 164 | 198.13 | 155.84 | 79.87 | Upgrade
|
Long-Term Deferred Charges | 121.35 | 117.84 | 62.57 | 26.97 | 5.29 | 20.51 | Upgrade
|
Other Long-Term Assets | 0.84 | 0.58 | 0.98 | 2.09 | 15.15 | 8.17 | Upgrade
|
Total Assets | 1,162 | 1,150 | 1,332 | 1,669 | 1,827 | 1,856 | Upgrade
|
Accounts Payable | 36.12 | 33.49 | 72.91 | 35.87 | 31.71 | 19.63 | Upgrade
|
Accrued Expenses | 19.95 | 20.12 | 83.85 | 158.73 | 150.01 | 127.99 | Upgrade
|
Short-Term Debt | 20.01 | 30.03 | 40.95 | 23.09 | - | 48 | Upgrade
|
Current Portion of Long-Term Debt | 0.06 | 0.06 | - | - | - | - | Upgrade
|
Current Portion of Leases | - | - | - | 2.69 | 2.25 | - | Upgrade
|
Current Income Taxes Payable | 2.18 | 1.65 | - | 0.02 | - | - | Upgrade
|
Current Unearned Revenue | 5.56 | 3.89 | 2.86 | 3.27 | 1.34 | 1.14 | Upgrade
|
Other Current Liabilities | 58.08 | 65.22 | 7.6 | 8.1 | 11.33 | 11.43 | Upgrade
|
Total Current Liabilities | 141.95 | 154.45 | 208.17 | 231.77 | 196.64 | 208.2 | Upgrade
|
Long-Term Leases | - | 0.06 | - | 3.18 | 5.37 | - | Upgrade
|
Long-Term Unearned Revenue | 29.18 | 29.91 | 29.24 | 33.47 | 21.32 | 23.35 | Upgrade
|
Long-Term Deferred Tax Liabilities | 48.43 | 48.43 | 74.14 | 47.03 | 52.91 | 33.83 | Upgrade
|
Other Long-Term Liabilities | - | - | - | - | - | 3.32 | Upgrade
|
Total Liabilities | 219.56 | 232.85 | 311.55 | 315.45 | 276.25 | 268.7 | Upgrade
|
Common Stock | 477.77 | 477.77 | 477.77 | 475.36 | 476.03 | 476.03 | Upgrade
|
Additional Paid-In Capital | 617.15 | 570.95 | 534.46 | 519.36 | 536.44 | 531.08 | Upgrade
|
Retained Earnings | -241.71 | -249.37 | -83.63 | 314.62 | 510.98 | 648 | Upgrade
|
Treasury Stock | - | - | - | - | -43.68 | -82.72 | Upgrade
|
Comprehensive Income & Other | 100.22 | 129.88 | 92.06 | 44.53 | 70.97 | 15.11 | Upgrade
|
Total Common Equity | 953.43 | 929.23 | 1,021 | 1,354 | 1,551 | 1,588 | Upgrade
|
Minority Interest | -10.73 | -12.47 | - | - | - | - | Upgrade
|
Shareholders' Equity | 942.7 | 916.76 | 1,021 | 1,354 | 1,551 | 1,588 | Upgrade
|
Total Liabilities & Equity | 1,162 | 1,150 | 1,332 | 1,669 | 1,827 | 1,856 | Upgrade
|
Total Debt | 20.06 | 30.14 | 40.95 | 28.96 | 7.63 | 48 | Upgrade
|
Net Cash (Debt) | 69.37 | 23.77 | 44.23 | 236.03 | 458.84 | 674.54 | Upgrade
|
Net Cash Growth | 103.11% | -46.26% | -81.26% | -48.56% | -31.98% | -14.60% | Upgrade
|
Net Cash Per Share | - | 0.05 | 0.09 | 0.49 | 0.97 | 1.42 | Upgrade
|
Filing Date Shares Outstanding | - | 526.49 | 477.77 | 475.36 | 472.66 | 469.65 | Upgrade
|
Total Common Shares Outstanding | - | 526.49 | 477.77 | 475.36 | 472.66 | 469.65 | Upgrade
|
Working Capital | 83.76 | 23.18 | 30.72 | 297.28 | 491.8 | 695.12 | Upgrade
|
Book Value Per Share | - | 1.76 | 2.14 | 2.85 | 3.28 | 3.38 | Upgrade
|
Tangible Book Value | 899.2 | 874.81 | 965.78 | 1,254 | 1,446 | 1,482 | Upgrade
|
Tangible Book Value Per Share | - | 1.66 | 2.02 | 2.64 | 3.06 | 3.16 | Upgrade
|
Buildings | - | - | 214.75 | 184.57 | 183.64 | 183.07 | Upgrade
|
Machinery | - | - | 318.38 | 254.98 | 246.28 | 237.66 | Upgrade
|
Construction In Progress | - | - | - | 87.82 | 85.48 | 52.92 | Upgrade
|
Updated Oct 24, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.